Apoptosis in human endometrium and endometriosis

被引:200
作者
Harada, T
Kaponis, A
Iwabe, T
Taniguchi, F
Makrydimas, G
Sofikitis, N
Paschopoulos, M
Paraskevaidis, E
Terakawa, N
机构
[1] Tottori Univ, Sch Med, Dept Obstet & Gynaecol, Yonago, Tottori, Japan
[2] Univ Ioannina, Sch Med, Dept Obstet & Gynaecol, GR-45110 Ioannina, Greece
[3] Univ Ioannina, Sch Med, Lab Mol Urol & Genet, Dept Urol, GR-45110 Ioannina, Greece
关键词
apoptosis; bcl-2; endometriosis; Fas; FasL system;
D O I
10.1093/humupd/dmh007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Apoptosis plays a critical role in maintaining tissue homeostasis and represents a normal function to eliminate excess or dysfunctional cells. Accumulated evidence suggests that apoptosis helps to maintain cellular homeostasis during the menstrual cycle by eliminating senescent cells from the functional layer of the uterine endometrium during the late secretory and menstrual phase of the cycle. The BCL-2 family and Fas/FasL system have been extensively studied in human endometrium and endometriotic tissues. Eutopic endometrium from women with endometriosis reportedly has some fundamental differences compared with normal endometrium of women without endometriosis. The differences could contribute to the survival of regurgitating endometrial cells into the peritoneal cavity and the development of endometriosis. One mechanism that recently gained a lot of interest is the finding that apoptosis appeared in eutopic and ectopic endometrium of patients with endometriosis. This study is a current review of the literature focused on the physiological role of apoptosis in normal endometrium and the alterations in regulation of apoptosis in eutopic and ectopic endometrium from women with endometriosis. Similarities in characteristics of endometriosis at a molecular level with gynaecological tumours are also discussed. Finally, the role of apoptosis in the treatment of endometriosis is reviewed to link the basic research findings into clinical applications.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 117 条
  • [1] Aplin AE, 1998, PHARMACOL REV, V50, P197
  • [2] Arimoto T, 2003, INT J ONCOL, V22, P551
  • [3] Menstrual characteristics associated with endometriosis
    Arumugam, K
    Lim, JMH
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (08): : 948 - 950
  • [4] Bartelmez GW., 1957, CONTRIB EMBRYOL, V36, P153
  • [5] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION
    BELLGRAU, D
    GOLD, D
    SELAWRY, H
    MOORE, J
    FRANZUSOFF, A
    DUKE, RC
    [J]. NATURE, 1995, 377 (6550) : 630 - 632
  • [6] Ben-Hur H, 1999, EUR J GYNAECOL ONCOL, V20, P249
  • [7] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
    BOISE, LH
    GONZALEZGARCIA, M
    POSTEMA, CE
    DING, LY
    LINDSTEN, T
    TURKA, LA
    MAO, XH
    NUNEZ, G
    THOMPSON, CB
    [J]. CELL, 1993, 74 (04) : 597 - 608
  • [8] BRAUN DP, 1992, FERTIL STERIL, V57, P1203
  • [9] Cytolysis of eutopic and ectopic endometrial cells by peripheral blood monocytes and peritoneal macrophages in women with endometriosis
    Braun, DP
    Gebel, H
    Rana, N
    Dmowski, WP
    [J]. FERTILITY AND STERILITY, 1998, 69 (06) : 1103 - 1108
  • [10] Endometriosis: candidate genes
    Campbell, IG
    Thomas, EJ
    [J]. HUMAN REPRODUCTION UPDATE, 2001, 7 (01) : 15 - 20